This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Live Nation fails to get out of US case alleging ticket sale monopoly

( April 11, 2025, 22:31 GMT | Official Statement) -- MLex Summary: Live Nation and Ticketmaster's motion to dismiss a proposed US class action accusing them of illegally monopolizing the primary and secondary markets for ticket sales has been denied. US District Judge George H. Wu found that the plaintiffs’ allegations that Ticketmaster controls 60 percent of the alleged submarket, in conjunction with its allegations that Ticketmaster has grown despite higher fees than competitors in a market that disfavors new market entrants, is sufficient to allege market power. However, Wu did dismiss without prejudice the plaintiffs' claims over agreements between the defendants and "artists and others," ruling that they "made no effort to contend with Defendants’ assertion that such allegations lack the requisite detail" and accepted at a hearing the court's tentative ruling to dismiss those claims.See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections